Drug Shortage Report for TEVA-TAMSULOSIN CR
Report ID | 190785 |
Drug Identification Number | 02368242 |
Brand name | TEVA-TAMSULOSIN CR |
Common or Proper name | TEVA-TAMSULOSIN 0.4MG CR TABS P/PACK 30 |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE |
Strength(s) | 0.4MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 30 |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-04-27 |
Estimated end date | 2024-09-30 |
Actual end date | 2024-10-01 |
Shortage status | Resolved |
Updated date | 2024-10-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | Yes |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v35 | 2024-10-15 | French | Compare |
v34 | 2024-10-15 | English | Compare |
v33 | 2024-09-19 | French | Compare |
v32 | 2024-09-19 | English | Compare |
v31 | 2024-06-27 | French | Compare |
v30 | 2024-06-27 | English | Compare |
v29 | 2024-05-09 | French | Compare |
v28 | 2024-05-09 | English | Compare |
v27 | 2024-05-03 | French | Compare |
v26 | 2024-05-03 | English | Compare |
v25 | 2024-04-25 | French | Compare |
v24 | 2024-04-25 | English | Compare |
v23 | 2024-03-07 | French | Compare |
v22 | 2024-03-07 | English | Compare |
v21 | 2024-01-30 | English | Compare |
v20 | 2024-01-08 | French | Compare |
v19 | 2024-01-08 | English | Compare |
v18 | 2023-12-14 | French | Compare |
v17 | 2023-12-14 | English | Compare |
v16 | 2023-12-07 | French | Compare |